Verona Pharma PLC (VRNA)
14.93
-0.76
(-4.84%)
USD |
NASDAQ |
May 06, 16:00
14.93
0.00 (0.00%)
After-Hours: 17:53
Verona Pharma Total Assets (Quarterly): 308.12M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 308.12M |
| September 30, 2023 | 292.47M |
| June 30, 2023 | 303.93M |
| March 31, 2023 | 323.15M |
| December 31, 2022 | 259.47M |
| September 30, 2022 | 274.87M |
| June 30, 2022 | 154.86M |
| March 31, 2022 | 169.32M |
| December 31, 2021 | 186.59M |
| September 30, 2021 | 201.56M |
| June 30, 2021 | 218.50M |
| March 31, 2021 | 190.15M |
| December 31, 2020 | 204.21M |
| September 30, 2020 | 245.83M |
| June 30, 2020 | 64.34M |
| March 31, 2020 | 44.36M |
| December 31, 2019 | 56.23M |
| September 30, 2019 | 67.05M |
| June 30, 2019 | 76.91M |
| March 31, 2019 | 85.04M |
| December 31, 2018 | 94.84M |
| September 30, 2018 | 99.89M |
| June 30, 2018 | 105.44M |
| March 31, 2018 | 116.27M |
| December 31, 2017 | 120.96M |
| Date | Value |
|---|---|
| September 30, 2017 | 127.14M |
| June 30, 2017 | 133.00M |
| December 31, 2016 | 56.93M |
| June 30, 2016 | 7.250M |
| June 30, 2016 | 7.250M |
| December 31, 2015 | 11.62M |
| June 30, 2015 | 15.33M |
| June 30, 2015 | 15.33M |
| December 31, 2014 | 20.43M |
| June 30, 2014 | 24.29M |
| June 30, 2014 | 24.29M |
| December 31, 2013 | 4.217M |
| June 30, 2013 | 4.259M |
| June 30, 2013 | 4.259M |
| December 31, 2012 | 4.529M |
| June 30, 2012 | 6.493M |
| June 30, 2012 | 6.493M |
| December 31, 2011 | 6.531M |
| June 30, 2011 | 4.701M |
| December 31, 2010 | 5.644M |
| June 30, 2010 | 6.862M |
| December 31, 2009 | 7.712M |
| June 30, 2009 | 5.415M |
| December 31, 2008 | 5.972M |
| June 30, 2008 | 9.587M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
44.36M
Minimum
Mar 2020
323.15M
Maximum
Mar 2023
191.68M
Average
201.56M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | 13.43M |
| NuCana PLC | 35.43M |
| TC BioPharm (Holdings) PLC | 11.38M |
| Adaptimmune Therapeutics PLC | 282.62M |
| Autolus Therapeutics PLC | 375.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 58.84M |
| Shareholders Equity (Quarterly) | 249.28M |